TIMP1 and ovarian cancer: (viii) Finally, the TCGA data sets suggests, the platinum response in ovarian cancer patients was related to the amplification of the TIMP and MMP genes; patients becoming sensitive to chemotherapy with TIMP mutations and resistant with MMP mutations.